Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 81 - 90 of 345

Selected Filters:
17 May 2023

Deep Dive Review of Modelling Long Acting PrEP Meeting Summary

In March 2023, the Bill and Melinda Gates Foundation convened modellers looking into the impact, costs, and/or cost effectiveness of cabotegravir (CAB) for PrEP in low and middle income countries. This meeting summary provides an overview of 11 models as well as key insights emerging from the models and knowledge gaps.

Research

Document
5 May 2023

Consolidated Guidelines on Person-centred HIV Strategic Information: Strengthening routine data for impact

These guidelines from the WHO, published in July 2022, focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer-term health care – building upon 2017 and 2020 strategic information guidelines. The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen…

Monitoring & Evaluation

Document
18 April 2023

Report: Formative research on CAB for PrEP in Eswatini

The goal of this study was to assess access needs, product acceptability, values, and preferences for the new PrEP method. This activity was a collaboration between EpiC and MOSAIC, and included adolescent girls and young women, men who have sex with men, people who inject drugs, female sex workers, pregnant and breastfeeding populations, and transgender…

Research

External Link
14 April 2023

Coordinating Implementation Science for CAB for PrEP: Bridging from the HPTN 083 and 084 Open Label Extensions to Implementation

This document summarises key takeaways from the BioPIC Think Tank on early insights from the HIV Prevention Trials Network (HPTN) 083 and 084 studies’ Open Label Extensions, looking at effectiveness of cabotegravir for PrEP as HIV prevention.

Research

Document
12 April 2023

Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction Report

This report was from the BioPIC Think Tank, Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction. As new HIV prevention products move closer to entering the market, there is an opportunity to design choice-based programs that apply lessons and successes from HIV and FP…

Demand Creation/Marketing

Document
31 March 2023

Private Sector Delivery Strategy for the Dual Prevention Pill: Kenya and Zimbabwe

This strategy was authored by the DPP Consortium to prepare for market entry of the DPP (Dual Prevention Pill) in Kenya and Zimbabwe.

Service Delivery

Document
29 March 2023

Rapid Assessment on Access to PrEP in EU/EEA Countries, 2022

This report clarifies the barriers to PrEP access in the EU/EEA countries, how they compare regionally, and what possible changes these countries can make to continue the fight against HIV.

Normative Guidance/Policies

Document
29 March 2023

Zimbabwe National HIV/AIDS Strategic Plan, 2021–25

In line with the global goal to eliminate HIV by 2030, the Zimbabwe National HIV and AIDS Strategic Plan guides the HIV programming, resource allocation and implementation of the HIV response for the next five years.

Normative Guidance/Policies

Document
29 March 2023

National HIV & AIDS Strategic Plan 2018/19-2022/23

Lesotho has committed to eliminating HIV/AIDS by 2030. Based on gains made in the last decade, Lesotho’s Ministry of Health developed this Strategic Plan to build an enabling environment to reach that goal. This plan outlines how the country will work with stakeholders to eliminate HIV/AIDS within its borders by 2030.

Normative Guidance/Policies

External Link
29 March 2023

National Strategic Plan for HIV/AIDS and STI, 2017 – 24

In 2016, India committed to the goal of ending AIDS as a public health threat by 2030. This national strategic plan provides methods and information on how the country intends on changing its healthcare approach to reach their goal.

Normative Guidance/Policies

Document